Johnson & Johnson Innovation and Janssen Award U.S. $1.5 Million in Grants for World Without Disease QuickFire Challenge
RMIT, Glyscend and Neurotrack each receive U.S. $500,000 research grant and offered residency at Johnson & Johnson Innovation | JLABS.
NEW YORK, Nov. 14, 2016 — Johnson & Johnson Innovation LLC and Janssen Research & Development, LLC (Janssen) today announced multiple recipients of U.S. $500,000 grants and offers of residency at Johnson & Johnson Innovation | JLABS (JLABS) in the World Without Disease QuickFire Challenge. The announcement was made at the 2016 Partnering for Cures conference. The competition was the largest and most ambitious Johnson & Johnson Innovation QuickFire Challenge to date, representing an ongoing commitment to support diverse life science innovations and the development of integrated, cross-sector solutions to prevent, intercept and cure diseases.
Download the PDF for the full press release.